Original fundamental research starts and ENDS here.
LOW
30 filings
Timeline Columns Start Research 8-K Categories
2025
Q4 3 filings
Nov
Q3 2025 Results
Rev $20.8B (+3.2% YoY), EPS $2.88 (-3.7% YoY)
Nov
Q3 Earnings
Q3 2025 results for quarter ended Oct 31, 2025
Oct
Acquired Foundation Building Materials
$8.8B cash deal completed
Q3 5 filings
Sep
Debt Offering
$5B notes issued, rates 3.95%-4.85%
Sep
Credit Facilities for ASP Acquisition
$5B in credit facilities ($2B revolving, $2B term loan, $1B 364-day) for $8.8B ASP acquisition
Aug
Q2 2025 Results
Rev $23.96B (+1.6% YoY), EPS $4.27 (+2.4% YoY)
Aug
Acquired Foundation Building Materials
$8.8B cash acquisition deal
Aug
Q2 Earnings
Q2 ended August 1, 2025
Q2 4 filings
Jun
Annual Shareholder Meeting
All 12 directors elected, executive compensation approved, Deloitte ratified as auditor
May
Q1 2025 Results
Rev $20.9B (down 2.0% YoY), EPS $2.92 (down from $3.06 YoY)
May
Q1 2025 Earnings
Q1 ended May 2, 2025 results announced
Apr
2025 Proxy Statement
CEO comp: Not disclosed, Say-on-pay: Advisory vote scheduled
Q1 2 filings
Mar
FY2024 2025 Results
Rev data not available in extract, EPS data not available in extract
📌 Fiscal year ended January 31, 2025 - financial performance metrics not clearly extractable from provided XBRL taxonomy data
Feb
Q4 Earnings
Q4 and FY2025 results for period ended Jan 31, 2025
2024
Q4 3 filings
Dec
2024 Analyst and Investor Conference
Affirmed full year 2024 financial outlook, provided 2025 scenario planning
Nov
Q3 2024 Results
Rev $20.17B, EPS $2.99 (Rev down 1.5% YoY, EPS down 2.6% YoY)
Nov
Q3 Earnings
Q3 2024 results for quarter ended Nov 1
Q3 2 filings
Aug
Q2 2024 Results
Rev $23.6B (-5.5% YoY), EPS $4.17 (-8.6% YoY)
Aug
Q2 Earnings
Q2 2024 results for quarter ended August 2, 2024
Q2 4 filings
Jun
Annual Shareholder Meeting
All 13 directors elected, exec comp approved, Deloitte ratified as auditor
May
Q1 2024 Results
Rev $21.4B vs $22.3B (-4.4% YoY), EPS $3.06 vs $3.77 (-18.8% YoY)
May
Q1 2024 Earnings
Q1 ended May 3, 2024 results
Apr
2024 Proxy Statement
Annual meeting: May 31, 2024, returned $8.9B to shareholders via buybacks/dividends in 2023
Q1 2 filings
Mar
FY2023 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Filed 10-K for fiscal year ended February 2, 2024, covering FY2023 performance period
Feb
Q4 Earnings
Q4 and FY2024 results for period ended Feb 2, 2024
2023
Q4 3 filings
Nov
Q3 2023 Results
Unable to extract specific revenue and EPS figures from provided XBRL data
Nov
Q3 Earnings
Q3 ended Nov 3, 2023 results
Oct
Director Resigned
Daniel J. Heinrich resigned from Board effective Oct 23, 2023
Q3 2 filings
Sep
Credit Facility Amendment
$2B revolving credit facility, matures Sept 2028
Aug
Q2 2023 Results
Unable to extract specific revenue and EPS figures from XBRL data